Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes for Angiogenesis.
Chengwei JuYoungjun LiYan ShenYutao LiuJingwen CaiNaifeng LiuGengshan MaYao Liang TangPublished in: Journal of cardiovascular translational research (2018)
We demonstrated the effects of exosomes secreted by cardiac mesenchymal stem cells (C-MSC-Exo) in protecting acute ischemic myocardium from reperfusion injury. To investigate the effect of exosomes from C-MSC on angiogenesis, we injected C-MSC-Exo or PBS intramuscularly into ischemic hind limb. Blood perfusion of limb was evaluated by laser Doppler Imaging. We observed that ischemic limb treated with C-MSC-Exo exhibits improved blood perfusion compared to ischemic limb treated with PBS at 2 weeks and 1 month after induction of limb ischemia. To explore the potential mechanisms underlying C-MSC-Exo's angiogenetic effect, we performed microRNA array analysis and identify mmu-miR-7116-5p as the most abundant enriched miRNA detected in C-MSC-Exo. Bioinformatics' analysis shows that miR-7116-5p negatively regulates protein polyubiquitination. In conclusion, our study demonstrated that intramuscular delivery of C-MSC-Exo after limb ischemia improves blood perfusion, and we identified the most abundant miRNAs that are preferentially enriched in C-MSC-Exo.
Keyphrases
- mesenchymal stem cells
- umbilical cord
- stem cells
- cerebral ischemia
- ischemia reperfusion injury
- high resolution
- bone marrow
- endothelial cells
- cell therapy
- left ventricular
- contrast enhanced
- acute myocardial infarction
- heart failure
- coronary artery disease
- vascular endothelial growth factor
- liver failure
- magnetic resonance imaging
- blood brain barrier
- computed tomography
- climate change
- respiratory failure
- blood flow
- amino acid
- high speed
- protein protein
- gestational age